Note: Ingredients listed on restricted chemical lists
EC/CAS
215-138-9/1305-78-8
Name of the chemical
Calcium oxide
Concentration
≥5-<10
EC/CAS
202-966-0/101-68-8
Name of the chemical
4,4’-Methylenediphenyl diisocyanate
Concentration
≥0.49-<1 00-9 0,1%≤C<100 5%≤C<100
EC/CAS
231-633-2/7664-38-2
Name of the chemical
phosphoric acid
Concentration
≥0.016- <0.025% 00-6 10%≤C<25
General Information
Revision date
2022-06-14
Product name
ULTRABOND P 990 1K
1.2.1 Relevant identified uses
Polyurethane-based adhesive
Emergency telephone
02 66101029, 06 49978000, 06 3054343
Icons in SDS
Company Information
company name
MAPEI S.p.A.
e-mail address of the competent person responsible for the Safety Data Sheet
sicurezza@mapei.it
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H318, H334
Hazard statements
Code
Statements
H318
Causes serious eye damage
Section 2
SECTION 2: Hazards identification
Adverse physicochemical, human health and environmental effects
No other hazards
Hazard statements
H318 Causes serious eye damage. H334 May cause allergy or asthma symptoms or breathing difficulties if inhaled.
Precautionary statements
P261 Avoid breathing mist/vapours/spray. P280 Wear protective gloves/clothing and eye/face protection. Print date 21/07/2022 Production Name ULTRABOND P 990 1K Page n. 1 of P304+P340 IF INHALED: Remove person to fresh air and keep comfortable for breathing. P305+P351+P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P310 Immediately call a POISON CENTER. P342+P311 If experiencing respiratory symptoms: Call a POISON CENTER or doctor/physician. P501 Dispose of contents/container in accordance with applicable regulations.
Special Provisions
EUH204 Contains isocyanates. May produce an allergic reaction.
Contains
calcium oxide diphenylmethane-4,4'-diisocyanate
Annex XVII - Restrictions on the manufacture, placing on the market and use of certain dangerous substances, mixtures and articles
As from 24 August 2023 adequate training is required before industrial or professional use.
2.3 Other hazards
No PBT, vPvB or endocrine disruptor substances present in concentration >= 0.1%. No other hazards
